Germany
Japan
United Kingdom
China
Rabbit monoclonal to Phospho-Histone H4 (Ser1), H4S1p
| Applications | ELISA, ICC, LMNX, WB |
| Reactivities | Human, Vertebrates |
| Conjugation | Unconjugated |
Products
View as table DownloadRabbit monoclonal to Phospho-Histone H4 (Ser1), H2A/H4S1p
| Applications | ELISA, ICC, LMNX, WB |
| Reactivities | Human, Vertebrates |
| Conjugation | Unconjugated |
Rabbit monoclonal to Phospho-Histone H3 (Ser10)
| Applications | ELISA, ICC, LMNX, WB |
| Reactivities | Human, Vertebrates |
| Conjugation | Unconjugated |
Rabbit monoclonal to Phospho-Histone H3 (Thr3)
| Applications | ELISA, ICC, IHC, LMNX, WB |
| Reactivities | Human, Vertebrates |
| Conjugation | Unconjugated |
Rabbit monoclonal to Phospho-Histone H3 (Thr6)
| Applications | ELISA, LMNX, WB |
| Reactivities | Human, Vertebrates |
| Conjugation | Unconjugated |
Rabbit monoclonal to Phospho-Histone H3 (Thr11)
| Applications | ELISA, LMNX, WB |
| Reactivities | Human, Vertebrates |
| Conjugation | Unconjugated |
Rabbit monoclonal to Trimethyl-Phospho-Histone H3 (Lys9/Ser10)
| Applications | ELISA, LMNX, WB |
| Reactivities | Human, Vertebrates |
| Conjugation | Unconjugated |
Rabbit monoclonal to Phospho-Histone H2B (Ser14)
| Applications | ELISA, ICC, LMNX, WB |
| Reactivities | Human, Vertebrates |
| Conjugation | Unconjugated |
Rabbit monoclonal to Gamma H2AX (phospho-Ser139)
| Applications | ELISA, ICC, LMNX, WB |
| Reactivities | Human, Vertebrates |
| Conjugation | Unconjugated |
mIgG (1,2a,2b,3) kappa light chain Specific Rabbit monoclonal antibody,OTIR12F3
| Applications | ELISA, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
mIgG (1,2a,2b,3) kappa light chain Specific Rabbit monoclonal antibody,OTIR12F3
| Applications | ELISA, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
hIgG Fcγ Fragment Specific Rabbit monoclonal antibody,clone OTIR7A7
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 180.00
2 Weeks
hIgG Lambda light chain Specific Rabbit monoclonal antibody,clone OTIR10C7
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
USD 180.00
2 Weeks
hIgG Lambda light chain Specific Rabbit monoclonal antibody,clone OTIR10H4
| Applications | ELISA, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Ac-tau274 Rabbit monoclonal antibody,clone OTIR10C1
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Ac-tau274 Rabbit monoclonal antibody,clone OTIR10C1
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Ac-tau274 Rabbit monoclonal antibody,clone OTIR10B2
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Ac-tau274 Rabbit monoclonal antibody,clone OTIR10B2
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Ac-tau274 Rabbit monoclonal antibody,clone OTIR11C9
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Ac-tau274 Rabbit monoclonal antibody,clone OTIR11C9
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
P-tau217 Rabbit monoclonal antibody,clone OTIR1A9
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
P-tau217 Rabbit monoclonal antibody,clone OTIR1A9
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
P-tau217 Rabbit monoclonal antibody,clone OTIR1A10
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
P-tau217 Rabbit monoclonal antibody,clone OTIR1A10
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
P-tau217 Rabbit monoclonal antibody,clone OTIR3B5
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
P-tau217 Rabbit monoclonal antibody,clone OTIR3B5
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Ac-tau281 Rabbit monoclonal antibody,clone OTIR5E7
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Ac-tau281 Rabbit monoclonal antibody,clone OTIR5E7
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Ac-tau281 Rabbit monoclonal antibody,clone OTIR5D9
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Ac-tau281 Rabbit monoclonal antibody,clone OTIR5D9
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Ac-tau281 Rabbit monoclonal antibody,clone OTIR5B10
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
Ac-tau281 Rabbit monoclonal antibody,clone OTIR5B10
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
P-tau181 Rabbit monoclonal antibody,clone OTIR1C12
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
P-tau181 Rabbit monoclonal antibody,clone OTIR1C12
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
P-tau181 Rabbit monoclonal antibody,clone OTIR5A6
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
P-tau181 Rabbit monoclonal antibody,clone OTIR5A6
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
P-tau181 Rabbit monoclonal antibody,clone OTIR2F8
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
P-tau181 Rabbit monoclonal antibody,clone OTIR2F8
| Applications | ELISA |
| Reactivities | Human |
| Conjugation | Unconjugated |
mIgLC Rabbit monoclonal antibody,clone OTIR1F4
| Applications | ELISA, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
mIgLC Rabbit monoclonal antibody,clone OTIR3F7
| Applications | ELISA |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Active filters
Clonalities
- Monoclonal
Assay Types
- Indirect
Filter by
Category
Target Symbol
- S (25)
- MAPT (24)
- MUC1 (10)
- TNF (9)
- CCR5 (8)
- N (8)
- CD4 (7)
- EGFR (7)
- CD52 (6)
- IL2RA (6)
- MSLN (6)
- VEGFA (6)
- VSIR (6)
- CD44 (5)
- CD80 (5)
- ERBB2 (5)
- H3-3A (5)
- AOC3 (4)
- BETVI (4)
- CCRL2 (4)
- FN1 (4)
- IL9 (4)
- INSR (4)
- ITGB2 (4)
- NOTCH2 (4)
- PXN (4)
- TIMD4 (4)
- TNFRSF8 (4)
- APP (3)
- CD28 (3)
- CD40 (3)
- F (3)
- ITGA5 (3)
- LEY (3)
- SLC3A2 (3)
- TYRP1 (3)
- ACKR1 (2)
- ADRB2 (2)
- AGER (2)
- AKT1 (2)
- ALB (2)
- ALBUMIN (2)
- C3AR1 (2)
- C5AR1 (2)
- CD163 (2)
- CD1A (2)
- CD40LG (2)
- CD55 (2)
- CD74 (2)
- CD81 (2)
- CMKLR1 (2)
- COX1 (2)
- CR1 (2)
- CTLA4 (2)
- CYSTATIN C (2)
- DDR1 (2)
- DSRNA (2)
- EDAR (2)
- EPCAM (2)
- EPHA2 (2)
- FABP3 (2)
- FAS (2)
- FCAR (2)
- FCGR2A (2)
- FGA (2)
- FGB (2)
- G1 (2)
- GM2 (2)
- GPR119 (2)
- GROUP ANTIGEN (2)
- GYPA (2)
- H3 (2)
- H4 (2)
- HIGG LAMBDA LIGHT CHAIN (2)
- IFNG (2)
- IGE (2)
- IGM (2)
- IL10 (2)
- IL16 (2)
- IL17A (2)
- IL18 (2)
- IL2 (2)
- IL4 (2)
- IL5 (2)
- IL6R (2)
- IL7R (2)
- ITGA2B (2)
- ITGA4 (2)
- ITGAM (2)
- ITGAX (2)
- LCN2 (2)
- LEP (2)
- LTA (2)
- MIGG (1,2A,2B,3) (2)
- MIGLC (2)
- NCAM1 (2)
- NOTCH1 (2)
- NTRK1 (2)
- PDCD1 (2)
- PHLPI (2)
Reactivities
- Human (333)
- Mouse (76)
- Rat (25)
- Monkey (13)
- Rabbit (9)
- Vertebrates (9)
- SARS-CoV (8)
- Pig (7)
- Cow (6)
- Porcine (6)
- Sheep (6)
- Chimpanzee (5)
- Dog (5)
- Bovine (4)
- Goat (4)
- Primate (4)
- Hamster (3)
- Respiratory Syncytial Virus (3)
- Chicken (2)
- Cynomolgus (2)
- Dengue virus (2)
- Feline (2)
- Ferret (2)
- Guinea Pig (2)
- Virus (2)
- West Nile Virus (2)
- Yellow Fever Virus (2)
- Zebrafish (2)
Applications
Antibody Hosts
Isotypes
Conjugates
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (47)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human Fab format, for improved compatibility with existing reagents, assays and techniques. (17)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (13)
- This chimeric human antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (12)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (12)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2b format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG1 format, for improved compatibility with existing reagents, assays and techniques. (7)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (6)
- This reformatted human antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (6)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2a format, for improved compatibility with existing reagents, assays and techniques. (5)
- This full-length, chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (5)
- This chimeric mouse antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original VHH format, for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG2a format, for improved compatibility with existing reagents, assays and techniques. (4)
- This full-length, reformatted human antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- This full-length, reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv format, for improved compatibility with existing reagents, assays and techniques. (4)
- This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (4)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (3)
- This chimeric rabbit antibody was made using the variable domain sequences of the original human scFv format, for improved compatibility with existing reagents, assays and techniques. (3)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (3)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- This full-length, chimeric mouse antibody was made using the variable domain sequences of the original Human scFv format, for improved compatibility with existing reagents, assays and techniques. (2)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This reformatted human antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgG2a format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric human antibody was made using the variable domain sequences of the original Mouse IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric murine antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Hamster IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgM format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Rat IgG2b format, for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original murine IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This is a chimeric mouse antibody, based on the original rat IgG2b format, created for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse IgG3 format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original Mouse scFv antibody fragment format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted mouse antibody was made using the variable domain sequences of the original mouse scFv format for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques. (1)
- This reformatted rat antibody was made using the variable domain sequences of the original Rat IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
Families
Pathways
- Alzheimer's disease (24)
- MAPK signaling pathway (24)
- Cytokine-cytokine receptor interaction (3)
- Adipocytokine signaling pathway (2)
- Jak-STAT signaling pathway (2)
- Neuroactive ligand-receptor interaction (2)
- PPAR signaling pathway (2)
- Bladder cancer (1)
- Chemokine signaling pathway (1)
- Epithelial cell signaling in Helicobacter pylori infection (1)
- NOD-like receptor signaling pathway (1)
- Pathways in cancer (1)
- RIG-I-like receptor signaling pathway (1)
- Toll-like receptor signaling pathway (1)